NCT06890884 · Interventional trial
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Overall registry status Recruiting
Phase 2
Conditions Lymphoma, Large B-Cell, Diffuse
Delaware Valley sites
- Abramson Cancer Center and Perelman Center for Advanced Medicine ( Site 0131) · Philadelphia, PA · Philadelphia County · Recruiting
- Alliance Cancer Specialists (ACS) ( Site 8010) · Sellersville, PA · Bucks County · Recruiting
- Temple University Hospital ( Site 0133) · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory